Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Musk Borrows $40 Billion for AI and Warns Rivals: Neocloud Providers Could Face Serious Trouble
Three markets to watch next week (23.10.2026)
Daily Summary: Oil at five-month highs, indices under pressure (23.10.2026)
US Open: Further declines on Wall Street, Brent above 111 USD, AI correction continues (14.10.2026)